139 related articles for article (PubMed ID: 16393861)
21. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells.
Prime-Chapman HM; Fearn RA; Cooper AE; Moore V; Hirst BH
J Pharmacol Exp Ther; 2004 Nov; 311(2):476-84. PubMed ID: 15210835
[TBL] [Abstract][Full Text] [Related]
22. Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection.
Lyseng-Williamson KA; Reynolds NA; Plosker GL
Drugs; 2005; 65(3):413-32. PubMed ID: 15669881
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of active renal tubular efflux of tenofovir.
Ray AS; Cihlar T; Robinson KL; Tong L; Vela JE; Fuller MD; Wieman LM; Eisenberg EJ; Rhodes GR
Antimicrob Agents Chemother; 2006 Oct; 50(10):3297-304. PubMed ID: 17005808
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity.
Potschka H; Fedrowitz M; Löscher W
J Pharmacol Exp Ther; 2003 Jul; 306(1):124-31. PubMed ID: 12663688
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver.
Zamek-Gliszczynski MJ; Xiong H; Patel NJ; Turncliff RZ; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2003 Feb; 304(2):801-9. PubMed ID: 12538836
[TBL] [Abstract][Full Text] [Related]
26. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
[TBL] [Abstract][Full Text] [Related]
27. Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats.
Suzuki T; Zhao YL; Nadai M; Naruhashi K; Shimizu A; Takagi K; Takagi K; Hasegawa T
Life Sci; 2006 Jun; 79(5):455-61. PubMed ID: 16483613
[TBL] [Abstract][Full Text] [Related]
28. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
[TBL] [Abstract][Full Text] [Related]
29. Disposition and sterol-lowering effect of ezetimibe in multidrug resistance-associated protein 2-deficient rats.
Oswald S; Westrup S; Grube M; Kroemer HK; Weitschies W; Siegmund W
J Pharmacol Exp Ther; 2006 Sep; 318(3):1293-9. PubMed ID: 16772539
[TBL] [Abstract][Full Text] [Related]
30. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
Maier-Salamon A; Hagenauer B; Reznicek G; Szekeres T; Thalhammer T; Jäger W
J Pharm Sci; 2008 Apr; 97(4):1615-28. PubMed ID: 17724663
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice.
Tian X; Zamek-Gliszczynski MJ; Li J; Bridges AS; Nezasa K; Patel NJ; Raub TJ; Brouwer KL
Drug Metab Dispos; 2008 Jan; 36(1):61-4. PubMed ID: 17913796
[TBL] [Abstract][Full Text] [Related]
32. Increased absorption of the antiviral ester prodrug tenofovir disoproxil in rat ileum by inhibiting its intestinal metabolism.
Van Gelder J; Deferme S; Annaert P; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
Drug Metab Dispos; 2000 Dec; 28(12):1394-6. PubMed ID: 11095573
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
[TBL] [Abstract][Full Text] [Related]
34. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein.
Ghanem CI; Gómez PC; Arana MC; Perassolo M; Ruiz ML; Villanueva SS; Ochoa EJ; Catania VA; Bengochea LA; Mottino AD
Biochem Pharmacol; 2004 Aug; 68(4):791-8. PubMed ID: 15276087
[TBL] [Abstract][Full Text] [Related]
35. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL
Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560
[TBL] [Abstract][Full Text] [Related]
37. Saturation of multidrug-resistant protein 2 (mrp2/abcc2)-mediated hepatobiliary secretion: nonlinear pharmacokinetics of a heterocyclic compound in rats after intravenous bolus administration.
Hu Y; Sampson KE; Heyde BR; Mandrell KM; Li N; Zutshi A; Lai Y
Drug Metab Dispos; 2009 Apr; 37(4):841-6. PubMed ID: 19139164
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers.
Kakuda TN; Schöller-Gyüre M; De Smedt G; Beets G; Aharchi F; Peeters MP; Vandermeulen K; Woodfall BJ; Hoetelmans RM
HIV Med; 2009 Mar; 10(3):173-81. PubMed ID: 19207601
[TBL] [Abstract][Full Text] [Related]
39. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems.
Hoffmaster KA; Zamek-Gliszczynski MJ; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2004 Dec; 311(3):1203-10. PubMed ID: 15302892
[TBL] [Abstract][Full Text] [Related]
40. Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated rats.
Villanueva SS; Ruiz ML; Soroka CJ; Cai SY; Luquita MG; Torres AM; Sánchez Pozzi EJ; Pellegrino JM; Boyer JL; Catania VA; Mottino AD
Drug Metab Dispos; 2006 Aug; 34(8):1301-9. PubMed ID: 16679389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
